The anti-gonadotropic effects of cytokines: The role of neuropeptides

Domestic Animal Endocrinology

Volumn 15, Issue 5, 1998, Pages 321-332

  Kalra, P S ^a   Edwards, T G ^a   Xu, B ^a   Jain, M ^a   Kalra, S P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; ENDOTOXIN; GONADORELIN; GONADOTROPIN; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUTEINIZING HORMONE; MESSENGER RNA; MU OPIATE RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROPEPTIDE; PROOPIOMELANOCORTIN; RECEPTOR SUBTYPE; TACHYKININ; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; BLOOD; CONFERENCE PAPER; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GONADORELIN RELEASE; HORMONE INHIBITION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; INFLAMMATION; LUTEINIZING HORMONE RELEASE; MALE; METABOLISM; NEUROENDOCRINE SYSTEM; NEUROSECRETORY CELL; NONHUMAN; PHYSIOLOGY; RAT; SECRETION;

ANIMALS; CYTOKINES; ENDOTOXINS; FEMALE; GENE EXPRESSION REGULATION; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS, PITUITARY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; INTERLEUKIN-1; LUTEINIZING HORMONE; MALE; NEUROPEPTIDES; PITUITARY-ADRENAL SYSTEM; RATS; RECEPTORS, NEUROKININ-2; RECEPTORS, OPIOID, MU;

EID: 0032173044     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0739-7240(98)00030-7     Document Type: Conference Paper

References (55)

1. Besedovsky HO, del Rey A, Sorkin E. Lymphokine containing supernatants from Con A-stimulated cells increase corticosterone blood levels. J Immunol 126:385-387, 1981.
2. Weigent DA, Blalock JE. Neuroendocrine-immune interactions. In: Immunology of the Nervous System, Keane RW, Hickey WF (eds). Oxford University Press, New York pp. 548-575, 1997.
3. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG. Release of multiple hormones by a direct action of IL-1 on pituitary cells. Science 238:519-521, 1987.
4. Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr Rev 17:64-102, 1996.
5. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. IL-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522-524, 1987.
6. Quagliarello VJ, Wispelwey B, Long WJ, Shield WM. Recombinant human IL-1 induced meningitis and blood-brain barrier injury in the rat. J Clin Invest 87:1360-1366, 1991.
7. Banks WA, Oritz L, Plotkin SR, Kastin AJ. Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharm Exp Thes 259:988-996, 1991.
8. Shibata M, Blatteis CM. Human recombinant TNF and interferon affect the activity of neurons in the organum vasculosum laminae terminalis. Brain Res 562:323-326, 1991.
9. Ericsson A, Kovacs KJ, Sawchenko PE. A functional neuroanatomical analysis of central pathways subserving the effects of IL-1 on stress-related neuroendocrine neurons. J Neurosci 14:897-913, 1994.
10. Schöbitz B, Ron de Kloet E, Holsboer F. Gene expression and function of IL-1, IL-6 and TNF in the brain. Prog Neurobiol 44:397-432, 1994.
11. Benveniste EN. Cytokine expression in the nervous system. In: Immunology of the Nervous System, Keane RW, Hickey WF (eds). Oxford University Press, New York pp. 419-459, 1997.
12. Wong M-L, Bongiorno PB, Retton V, McCann SM, Licinio J. Interleukin (IL)-1b, IL-1 receptor antagonist, IL-10 and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc Natl Acad Sci 94:227-232, 1997.
13. Breder CD, Dinarello CA, Saper CB. IL-1 immunoreactive innervation of the human hypothalamus. Science 240:321-324, 1988.
14. Lin C, Takao T, Hashimoto K, DeSouza EB. IL-1 receptors in the nervous system. In: Cytokines in the Nervous System, Rothwell NJ (ed). R.G. Landis Co., Austin, TX pp. 21-40, 1996.
15. Rivier C, Vale W. Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat. Endocrinology 127:849-859, 1990.
16. Kalra PS, Kalra SP. In vivo and in vitro models for evaluating effects of IL-1 on hypothalamic-pituitary gonadal axis. In: Neurobiology of Cytokines Part A, DeSouza EB (ed). Methods in Neuroscience, Academic Press, Inc., San Diego, CA 16:248-268, 1993.
17. Kalra PS, Sahu A, Kalra SP. IL-1 inhibits the ovarian-steroid induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats. Endocrinology 126:2145-2152, 1990.
18. Bonavera JJ, Kalra SP, Kalra PS. Mode of action of IL-1 in suppression of pituitary LH release in castrated male rats. Brain Res 612:1-8, 1993.
19. Rivest S, Rivier C. IL-1β inhibits the endogenous expression of the early gene c-FOS located within the nucleus of LHRH neurons and interferes with hypothalamic LHRH release during proestrus in the rat. Brain Res 613:132-142, 1993.
20. Nappi RA, Rivest S. Effect of immune and metabolic challenges on the luteinizing hormone-releasing hormone neuronal system in cycling female rats: An evaluation at the transcriptional level. Endocrinology 138:1374-1384, 1997.
21. Rivest S, Lee S, Attardi B, Rivier C. The chronic intracerebroventricular infusion of IL-1β alters the activity of the hypothalamic-pituitary-gonadal axes of cycling rats, I: Effects on LHRH and gonadotropin biosynthesis and secretion. Endocrinology 133:2424-2430, 1993.
22. Dunn AJ. Systemic IL-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci 43:429-435, 1988.
23. Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R, Asai M. IL-1β augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus. J Neurosci 13:3574-3581, 1993.
24. Rothwell NJ. Functions and mechanisms of IL-1 in the brain. Trends Pharmacol Sci 12:430-436, 1991.
25. Laskin JD, Heck DE, Laskin DL. Multifunctional role of nitric oxide in inflammation. Trends Endocrinol Metabol 5:377-382, 1994.
26. Turnbull AV, Rivier C. Cytokine effects of neuroendocrine axes: influence of nitric oxide and carbon monoxide. In: Cytokines in the Nervous System, Rothwell NJ (ed). R.G. Landis Co. pp. 93-116, 1996.
27. Rivier C. Influence of immune signals on the hypothalamic pituitary axis of the rodent. Front Neuroendocr 16:151-182, 1995.
28. 2 release to suppress pulsatile release of luteinizing hormone but not follicle-stimulating hormone. Proc Natl Acad Sci USA 88:2763-5767, 1991.
29. Rivest S, Rivier C. Centrally injected IL-1β inhibits the hypothalamic LHRH secretion and circulating LH levels via prostaglandins in rats. J Neuroendocrinol 5:445-450, 1993.
30. Suda T, Tozawa F, Ushiyama T, Sumitomo T, Yamada M, Denure H. IL-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology 126:1223-1228, 1990.
31. Rivest S, Rivier C. Influence of the paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine function induced by intermittent footshock or interleukin. Endocrinology 129:2049-2057, 1991.
32. Feng Y-J, Shalts E, Xia L, Rivier J, Rivier C, Vale W, Ferin M. An inhibitory effect of IL-1α on basal gonadotropin release in the ovariectomized rhesus monkey: Reversal by corticotropin-releasing factor antagonist. Endocrinology 128:2077-2082, 1991.
33. Kalra SP, Kalra PS. Neural regulation of luteinizing hormone secretion in the rat. Endocr Rev 4:311-351, 1983.
34. Heijnen CJ, Kavelaars A, Ballieux RE. β-endorphin: Cytokine and neuropeptide. Immunol Rev 119:41-63, 1991.
35. Carr DB, Bergland R, Hamilton A, Blume H, Kasting N, Arnold M, Martin JB, Rosenblatt M. Endotoxin-stimulated opioid peptide secretion: Two secretory pools and feedback control in vivo. Science 217:845-848, 1982.
36. Brown SL, Smith LR, Blalock JE. IL-1 and IL-2 enhance pro-opiomelanocortin gene expression in pituitary cells. J Immunol 139:3181-3183, 1987.
37. Kalra PS, Fuentes M, Sahu A, Kalra SP. Endogenous opioid peptides mediate the IL-1 induced inhibition of the release of luteinizing hormone releasing hormone and luteinizing hormone. Endocrinology 127:2381-2386, 1990.
38. Edwards TG, Xu B, Farmerie WA, Freund G, Kalra PS. Cytokines stimulate endogenous opioid activity in the hypothalamus: Involvement in gonadotropin secretion. 27th Ann Mtg Soc for Neuroscience (Abstract) 23:1510, 1997.
39. Ericcson A, Liu C, Hart RP, Sawchenko PE. Type 1 IL-1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361:681-389, 1995.
40. Rivest S, Rivier C. The role of corticoptropin-releasing factor and IL-1 in the regulation of neurons controlling reproductive functions. Endocr Rev 16:177-199, 1995.
41. Leranth C, MacLusky NJ, Shanabrough M, Naftolin F. Immunohistochemical evidence for synaptic connections between pro-opiomelanocortin-immunoreactive axon and LH-RH neurons in the preoptic area of the rat. Brain Res 449:167-176, 1988.
42. Valentino KL, Tatemoto K, Hunter J, Barchas JD. Distribution of neuropeptide K - immunoreactivity in the rat central nervous system. Peptides 7:1043-1059, 1986.
43. Magoul R, Onteniente B, Benjelloun W, Tramu G. Tachykinergic afferents to the rat arcuate nucleus: A combined immunohistochemical and retrograde tracing study. Peptides 14:275-286, 1993.
44. Harlan RE, Garcia MM, Krause JE. Cellular localization of Substance P - and Neurokinin A - encoding preprotachykinin mRNA in the female rat brain. J Comp Neurol 287:179-212, 1989.
45. Magoul R, Dubourg P, Benjelloun W, Tramu G. Synaptic inputs of tachykinin-containing nerve terminals to target tyrosine-hydroxylase, β-endorphin and NPY-producing neurons of the arcuate nucleus: Double pre-embedding immunohistochemical study in the rat. J Chem Neuroanat 6:419-429, 1993.
46. Brown EA, Harlan RE, Krause JE. Gonadal steroid regulation of substance P (SP) and SP-encoding messenger ribonucleic acid in the rat anterior pituitary and hypothalamus. Endocrinology 126:330-340, 1990.
47. Kalra PS, Dube MG, Kalra SP. The effects of IL-1β on the hypothalamic tachykinin, neurokinin A. Brain Res 662:178-184, 1994.
48. Kalra PS, Sahu A, Bonavera JJ, Kalra SP. Diverse effects of tachykinins on luteinizing hormone release in male rats: Mechanism of action. Endocrinology 131:1195-1201, 1992.
49. Kalra PS, Kalra SP. Neuropeptide K stimulates corticosterone release in the rat. Brain Res 610:330-333, 1993.
50. Berman AS, Chancellor-Freeland C, Zhu G, Black PH. Substance P primes murine peritoneal macrophages for an augmented proinflammatory cytokine response to lipopolysaccharide. NeuroImmunoModulation 3:141-149, 1996.
51. Freidin M, Kessler JA. Cytokine regulation of Substance P expression in sympathetic neurons. Proc Natl Acad Sci 88:3200-3203, 1991.
52. O'Donohue TL, Helke CJ, Shults CW, Buck SH, Burcher E. Tachykinin receptors. In: Handbook of Chemical Neuroanatomy. Vol. 9 Neuropeptides in the CNS. Part II, Bjorklund A, Hökfelt T, Kuhar MJ (eds). Elsevier, Amsterdam pp. 395-442, 1990.
53. Kalra PS, Dube MG, Xu B. Evidence that hypothalamic tachykinin NK-2 receptor activation mediates the neuroendocrine effects of IL-1β. 77th Ann Mtg Endocrine Soc (Abstract) p. 55, 1995.
54. Kalra PS, Dube MG, Kalra SP. Stimulation of hypothalamic tachykinin levels and release of IL-1β. 76th Ann Mtg Endocrine Soc (Abstract) p. 185, 1994.
55. Magoul R, Tramu G. Tachykinin-induced changes in β-endorphin gene expression in the rat arcuate nucleus. Neurosci Lett 223:93-96, 1997.